Letters New drugs for hyponatraemia Cost effectiveness of tolvaptan BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1947 (Published 29 March 2011) Cite this as: BMJ 2011;342:d1947 Article Related content Metrics Responses Peer review Related articles Editorial New drugs for hyponatraemia Published: 15 November 2010; BMJ 341 doi:10.1136/bmj.c6219 Letter Authors’ reply Published: 18 April 2011; BMJ 342 doi:10.1136/bmj.d2445 See more Advice on sugar and starch is urged in type 2 diabetes counselling BMJ December 06, 2016, 355 i6543; DOI: https://doi.org/10.1136/bmj.i6543 Generics have a chequered recent history BMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527 UK clinics may be able to offer mitochrondrial donation next spring BMJ December 01, 2016, 355 i6492; DOI: https://doi.org/10.1136/bmj.i6492 Individualised advice on type 2 diabetes is no better for changing behaviour, study finds BMJ November 30, 2016, 355 i6444; DOI: https://doi.org/10.1136/bmj.i6444 Saturated fat and heart disease BMJ November 23, 2016, 355 i6257; DOI: https://doi.org/10.1136/bmj.i6257 Cited by... Efficacy and safety of tolvaptan in hospitalised patients: a single-centre experienceAbstract Fulltext PDF Authors' replyAbstract Fulltext PDF